| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b318163a7ae014059af89ce98a9b603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5930a05dd7c3b2738eca6d8690e22166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc7643c94d356b0ab7cf1fffd061e8bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a45089bf68d048cbf48a64c389bda0f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c782aa463c7bcad8602477727347ea3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2329088652523dd9ab234584d08cf8aa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-04003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20 |
| filingDate |
2003-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ce7085560330b1855ea71f318b74b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34608b784b1176bb9a35add0357e95cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad2dddbf7a25ea49831c6eac76e252d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6b7755021ef5aabef2c556e44f9c3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45988dfe030df9099cd77c7097133c86 |
| publicationDate |
2004-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004020619-A9 |
| titleOfInvention |
Modified phospholipase c-gamma-2, expression products, and non-human animal models comprising said genes, and therapeutic uses |
| abstract |
Disclosed are (1) a nucleic acid sequence encoding a novel mutant PLCϜ-2 protein which, when expressed in a mammal is capable of enhancing the inflammation response and suppressing male fertility; (2) the mutant PLCϜ-2 protein which includes at least one amino acid residue substitution corresponding to residue 993 of the normal PLCϜ-2 protein; (3) a cell line or strain transfected with said nucleic acid sequence; (4) compositions comprising said nucleic acid or said protein and (5) a transgenic non-human comprising said DNA and protein. |
| priorityDate |
2002-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |